Literature DB >> 15119769

Persistent infection and suppression of host response by alphaviruses.

I Frolov1.   

Abstract

Alphaviruses cause chronic noncytopathic infection in mosquito cells and develop a highly cytopathic infection in a wide variety of cells of vertebrate origin. Upon infection, alphaviruses modify cellular processes to meet the virus needs for propagation. Downregulation of translation and transcription caused by viral infection appears to reduce interferon (IFN) and cytokine gene expression and allows more efficient dissemination of infection. Alphaviruses with mutations in nonstructural protein nsP2 can become less cytopathic and capable of persisting in some vertebrate cell lines for a number of passages. nsP2 likely functions as an important regulator of virus-host cell interactions and plays a significant role in suppressing the antiviral response. Mammalian cells having no defects in type I IFN system react to replication of the nsP2 viral mutants by more efficient activation of IFN and IFN-dependent genes and are capable of eliminating established alphavirus infection. Blocking of IFN-alpha/beta signaling makes mouse fibroblasts unable to stop replication of Sindbis virus (SINV) with mutated nsP2 and leads to persistent infection. Downregulation of transcription and translation during alphavirus infection are quite independent events, and both probably are involved in inhibition of the antiviral response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15119769     DOI: 10.1007/978-3-7091-0572-6_12

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  7 in total

Review 1.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.

Authors:  Jelke J Fros; Wen Jun Liu; Natalie A Prow; Corinne Geertsema; Maarten Ligtenberg; Dana L Vanlandingham; Esther Schnettler; Just M Vlak; Andreas Suhrbier; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Semliki Forest virus nonstructural protein 2 is involved in suppression of the type I interferon response.

Authors:  Lucy Breakwell; Pia Dosenovic; Gunilla B Karlsson Hedestam; Mauro D'Amato; Peter Liljeström; John Fazakerley; Gerald M McInerney
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

4.  An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo.

Authors:  Amy C Wollish; Martin T Ferris; Lance K Blevins; Yueh-Ming Loo; Michael Gale; Mark T Heise
Journal:  Virology       Date:  2012-10-17       Impact factor: 3.616

5.  Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection.

Authors:  Yee Suan Poo; Penny A Rudd; Joy Gardner; Jane A C Wilson; Thibaut Larcher; Marie-Anne Colle; Thuy T Le; Helder I Nakaya; David Warrilow; Richard Allcock; Helle Bielefeldt-Ohmann; Wayne A Schroder; Alexander A Khromykh; José A Lopez; Andreas Suhrbier
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

6.  Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug-Design.

Authors:  Sharon Shechter; David R Thomas; Lindsay Lundberg; Chelsea Pinkham; Shih-Chao Lin; Kylie M Wagstaff; Aaron Debono; Kylene Kehn-Hall; David A Jans
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

7.  Characterization of reemerging chikungunya virus.

Authors:  Marion Sourisseau; Clémentine Schilte; Nicoletta Casartelli; Céline Trouillet; Florence Guivel-Benhassine; Dominika Rudnicka; Nathalie Sol-Foulon; Karin Le Roux; Marie-Christine Prevost; Hafida Fsihi; Marie-Pascale Frenkiel; Fabien Blanchet; Philippe V Afonso; Pierre-Emmanuel Ceccaldi; Simona Ozden; Antoine Gessain; Isabelle Schuffenecker; Bruno Verhasselt; Alessia Zamborlini; Ali Saïb; Felix A Rey; Fernando Arenzana-Seisdedos; Philippe Desprès; Alain Michault; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.